? Hepatitis B virus is carcinogenic [3] , and the C virus has been implicated in the pathogenesis of liver cancer [3, 4] . Because of the evolution from chronic hepatitis of various origins to, in most cases, cirrhosis and then liver cancer, the need often arises to differentiate liver cirrhosisfrom HC. Furthermore, because HC is frequently superimposed on preexisting cirrhosis, monitoring cirrhotic patients for early recognition of neoplasia is essential for optimum treatment of HG. Several diagnostic procedures used thus far have proved to be less than satisfactory.
Computed tomography has a low sensitivity in detecting neoplastic evolution in cirrhotic patients [5] ; similarly, magnetic resonance imaging has bow diagnostic efficiency for correctly classifying malignant vs nonmalignant liver diseases [6, 7] . In other cases, the instrumental approaches may be more sensitive but are based on invasive procedures, such as ultrasound scanning-guided fine-needle aspiration [8] . Finally, the clotting disorders typical of advanced cirrhosis often preclude liver biopsy via baparoscopy.
Within the realm of biochemical signals, high serum concentrations of cs-fetoprotein (AFP) are claimed to be strongly predictive of HG [9] , but AFP has a low diagnostic sensitivity (-50%) and is thus not a great aid in differential and early All 77 cases of HG (total of both cohorts) were superimposed on liver cirrhosis. Most of the HG were also classified on the basis of the number of liver lesions (1 lesion, 35 HG; 2 lesions, 10 HG; 3 or 4 lesions, 6 HG; diffuse HG, 13 cases)and the diameter (or the sum of diameters for multiple-lesion HG) of the neoplastic lesion (<5 cm, 12 HG; 5-10 cm, 16 HG; >10 cm, 16 HG). The number of cases included in this study does not reflect the prevalence of the two diseases in our geographical area, but does reflect the prior prevalence of cirrhosis and HG (-2:1) seen in a highly specialized Hepatology Division in the Naples area.
ANALYTICAL METHODS
Serum from each patient was collected and processed within 2 h for the analysisof lactatedehydrogenase (LD) and LD isoen- Serum LD and AP isoenzymes were analyzed after zone electrophoresiswith materialsfrom Helena Labs. (Beaumont, TX). Serum GGT isoenzymes were analyzed with a previously described cellulose acetate electrophoretic procedure [21, 22] , and the GGT isoforms complexed with low-density lipoproteins were analyzed with the precipitation method previously described [23, 24] . Serum copper was analyzed by atomic absorption spectrometry (flame method; samples predibuted with 10 mL/L nitric acid) at 324.8 nm (Perkin-Elmer, Norwalk, CT). The same methods were used to analyze the various biochemical indices during the whole period of the study. Inaccuracy, checked by using both intra-and interlaboratomy qualitycontrol systems, was practically constant: GVs were <5.0% for all analytes except the GGT, AP, and LD isoenzymes, for which the GVs were always <10%.
STATISTICAL ANALYSES
We applied the statistical procedure previously used to select a panel of ascitic biochemical indices to discriminate malignant ascites from ascites that was due to liver cirrhosis or to HG [16] . We have also used this procedure to select a panel of serum biochemical indices that discriminates HG from secondary liver cancer [17] . The distribution of all the analyte values in HG and cirrhosis patients were compared by the nonparametric MannWhitney test.After evaluating the diagnostic sensitivity-i.e., true positive/(true positive + false negative), diagnostic specificity-i.e., true negative/(true negative + falsepositive) and diagnostic efflciency-(true positives + true negatives)/grand total of tested subjects-as described by Galen and Gambino [25] , we used receiver-operating characteristic (ROG) plots [26] to determine the best cutoff values for the analytes and for the discriminant function (see below) [26] . To compare the ROG plots, we compared the areas under the curves [26] .
The fitting of all the analytes to a gaussian distribution was checked with the Shapiro-Wilks method. Most of the variables deviated significantly from gaussian distribution in original scale; in subsequent procedures, therefore, we used the natural logarithm (In) of the results for all the anabytes. The ln transformation of the results yielded a gaussian distribution for all the analytes except AFP. In any case, however, MDA is reasonably robust against deviations from gaussian distribution. analysis [28] . The MDA was carried out stepwise with use of the minimum Wilks' lambda (ratio between within-groups sum of squares and the total sum of squares) to evaluate the group discrimination.
At the first step, the variable with the greatest discriminant power was selected; at each of the following steps, the selection criteria were reevaluated for all variables not in the model, and the one with the largest acceptable criterion value was included. The variables previously selected were reevaluated to check if they met the removal criterion. Any variable that met this criterion was removed, and the variable selection was concluded when no more variables met entry or removal criteria.
The discriminant score, calculated for each patient on the basis of a linear combination of variables selected by MDA, was used to classify the patients into one of two groups, according to Bayes' rule [29] , which takes into account not only the probability that a case belongs to one of two groups on the basis of the discriminant score (conditional probability) but also the inherent probability that the case belongs to one of the two groups in the absence of any information (prior probability). In our case, the observed proportions of cases in each group were used as estimates of the prior probabilities because we considered our sample to be representative of the patient population. The diagnosticsensitivity and specificity of the discrimination function were evaluated by taking into account the rate of misclassification of this reallocation method. We used two statistical techniques to cross-validate the results of the MDA on the first cohort of patients. First, we used the jackknife procedure, in which one patient at a time is excluded, the rule is rederived from the remaining data, and the rederived rube is used to classify the excluded patient [29] . This algorithm removes much of the bias of the simple reallocation method [27] . Second, we tested the validity of the discriminant function prospectively with 104 patients (38 HG and 66 cirrhosis) recruited later (199 .
After the positive check of the validity of the first discriminant function, we calculated a second function to cover the overall population, i.e., a pool of the two cohorts studied. The validity of this second MDA was also verified by the jackknife reallocation method, which confirmed the correct classification rate of the MDA.
Results
In this long-term study of cirrhotic and HG cases we measured a large variety of biochemical tests, including all the major markers used so far, to differentiate between the two phases of chronic liver disease. Table  I shows the analytes that were significantly different between the two disorders (P <0.01, nonparametric Mann-Whitney U-test) for the first cohort of patients. Notwithstanding the high significance of the differences in the mean values for all these analytes, there was always some degree of overlap between the cases of the two clinical situations, so that no cutoff value efficiently discriminated HG from cirrhotic patients. To enhance the discrimination power, we entered all of the anabytes into the SPSS computer program for MDA, after having bog-transformed their measured values; we alsospecified a prevalenceof 2:1 for cirrhosis vs HG. Total protein, bilirubin, alanine aminotransferase, cholinesterase, iron,LD isoenzymes 2-4, cholesterol, and triglycerides were excluded from the Wibks analysis of the MDA because they were correlated to other, more significant, variables [28] .
Among the variables inserted, the statistical procedure se- Fig. 2 ). The best curve cy). The diagnostic sensitivity of the MDA score for HG detecagain confirmed that the overall MDA selected with very high tion is 100% in the HG subgroup with >2 lesions and in the HG diagnostic efficiency the same analytes previously chosen in the subgroup with total lesion diameter >10 cm. However, the two separate cohorts of patients. The final equation is reported diagnostic sensitivity for single-lesion HG was 69.2%, and that in Table 3. for HG with a totallesiondiameter <5 cm was 75%. To further validate the final discriminant equation, we Figure 3 shows the probability for each patient of being checked it by the jackknife reallocation algorithm and again confirmed its high discriminatory power: diagnostic sensitivity #{149} .':. affectedby either of the two diseases on the basis of the individual discriminant scores. Thus, by consulting the MDA score, one may predict the probability for each individual patient of being affected by HG.
#{149}
During the study, we had the opportunity of observing six cases of liver cirrhosis that evolved to HG. The MDA of these patients calculated at diagnosis showed that five of them were classified as HG and not as cirrhosis; at that time, however, all the other clinical, histological, and instrumental indicators favored a diagnosis of liver cirrhosis. Only after 6-12 months did histology show a clear picture of HG in these five patients.
-. Table 4 shows the values of the MDA in these six patients at diagnosis, together with the probability each patient at that time had of being affected by HG, as the Bayesian curve clearly shows (Fig. 3) .
#{149}, #{149}

Discussion
The incidence of HG is increasing in most countries [1] , but also treatment of neoplasia is becoming increasingly efficient. The effects are obviously rebated to a timely diagnosis. Because most HG cases develop after cirrhosis, there is often the need to discriminate between these clinically confounding disorders. Imaging and other instrumental techniques are usually invasive or insufficiently sensitive, particularly for small lesions [30, 31] ; for example, one must sample the nodules, particularly HG nodules, by needle biopsy, which can be difficult because very small nodules can elude the imaging technology used. Moreover, the diagnostic efficiency of the individual biochemical indices described above ranges over a wide spectrum but never completely discriminates between HG and cirrhosis. The GGT isoforms complexed with low-and very-low-density lipoprotein discriminate HG from cirrhosis with a diagnostic efficiency of -85% [22] ; 50% of HG are associated with significantly increased values of serum AFP [9] ; and AFP isoforms have a diagnostic efficiency of -80% [11] . G-reactive protein is no more efficient than AFP [15] . Also in the present study, none of the biochemical variables evaluated discriminated between HG and cirrhosis satisfactorily because of the barge overlap of values between the two populations.
Therefore, the panel of analytes included in the discriminantfunction appears so farto be the best indicatorto discriminatebetween livercirrhosis and HG. Some cases of HG have a multiclonal origin [18] ; thus, the combination of unrelated variables [27] , each reflecting different biochemical abnormalities associated with neoplasia, increases the diagnostic efficiency of the variables in our panel. Fluctuations of LD concentration reflect the impaired glycobytic metabolism in cancer cells [32] ; LD isoenzyme 5 is produced predominantly by muscle and liverand isincreasedin the serum of HG patients [32] . The fraction of GGT complexed to lowand very-low-density lipoprotein (an adjunctive tool with which to discriminate HG from cirrhosis) is a signal of the cholestasis associated with HG [22] . The hepatic isoenzyme of AP is overproduced by neoplastic liver cells [33] , and serum copper is increased in HG because of the reduced biliary excretion of the ion and the increased production by neoplastic cells of fetal copper-binding proteins [14] . Finally, the increase in serum AFP in HG patients is due to the reexpression of the related gene, which is usually repressed in adult subjects. [6] , and that of cytology by fine-needle aspiration biopsy for HG was <85% [34] .
An additional result of our study is the probability plot, which allows calculation on the basis of the MDA score of each patient's probability for being affected by HG. This can help physicians to plan the best therapeutic strategy for each patient, e.g., invasive diagnostic approaches, further monitoring, therapy, and so on.
The MDA panel we present also indicated the presence of HG in five of the six patients affected by cirrhosis that during the study evolved to neoplasia.
The bead time for this was -6-12 months ahead of the other diagnostic approaches, including histology.
Combined with an acceptable diagnostic sensitivity (75%) of the MDA for HG with a diameter <5 cm, this result is relevant for screening for early diagnosis of HG. Although ultrasound and AFP have been proposed for the screening of general populations [9] , their cost in a population screening for HG would be very high [35] . Given that the risk categories for HG have been clearly identified, a screening program should be limited to these high-risk groups, i.e., subjects with cirrhosis and chronic hepatitis from hepatitis B and C viruses. The relatively low cost of using this noninvasive procedure involving a panel of biochemical tests could make it a valid contributory tool for HG screening.
In conclusion, with all the caution accorded to generalizations, the combination of unrelated biochemical tests selected by the MDA as reported here is an efficient tool for the differential diagnosis of cirrhosis and HG, and perhaps also for the monitoring of high-risk groups who may be evolving to HG, i.e., for the early identification of the neoplasia.
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